A direct injection high‐throughput liquid chromatography tandem mass spectrometry method for the determination of a new orally active αvβ3 antagonist in human urine and dialysate
- 23 October 2003
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 17 (22) , 2475-2482
- https://doi.org/10.1002/rcm.1221
Abstract
A generic high-throughput liquid chromatography (HTLC) tandem mass spectrometry (MS/MS) assay for the determination of compound I in human urine and dialysate (hemodialysis) was developed and validated. By using the HTLC on-line extraction technique, sample pretreatment was not necessary. The sample was directly injected onto a narrow bore large particle size extraction column (50 × 1.0 mm, 60 μm) where the sample matrix was rapidly washed away using a high flow rate (5 mL/min) aqueous mobile phase while analytes were retained. The analytes were subsequently eluted from the extraction column onto an analytical column using an organic-enriched mobile phase prior to mass spectrometric detection. The analytes were then eluted from the analytical column to the mass spectrometer for the determination. The linear dynamic range was 2.0–6000 ng/mL for the urine assay and 0.1–300 ng/mL for the dialysate assay. Intraday accuracy and precision were evaluated by analyzing five replicates of calibration standards at all concentrations used to construct the standard curve. For the urine assay, the precision (RSD%, n = 5) ranged from 1.9 to 8.0% and the accuracy ranged from 87.8 to 105.2% of nominal value. For the dialysate assay, the precision (RSD%, n = 5) ranged from 1.1 to 10.0% and the accuracy from 94.5 to 105.2% of nominal value. In-source fragmentation of the acyl glucuronide metabolite (compound III) did not interfere with the determination of parent compound I. The developed HTLC/MS/MS methodology was specific for compound I in the presence of compound III. Column life-time is increased and sample analysis time is decreased over traditional reversed-phase methods when direct injection assays for urine and dialysate are coupled with the technology of HTLC. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 9 references indexed in Scilit:
- A rapid and sensitive liquid chromatography/negative ion tandem mass spectrometry method for the determination of an indolocarbazole in human plasma using internal standard (IS) 96‐well diatomaceous earth plates for solid‐liquid extractionRapid Communications in Mass Spectrometry, 2002
- Determination of a β3-agonist in human plasma by LC/MS/MS with semi-automated 48-well diatomaceous earth plateJournal of Pharmaceutical and Biomedical Analysis, 2001
- High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasmaRapid Communications in Mass Spectrometry, 2000
- Quantitative analysis of terbinafine (Lamisil ) in human and minipig plasma by liquid chromatography tandem mass spectrometryRapid Communications in Mass Spectrometry, 2000
- Direct analysis of crude plasma samples by turbulent flow chromatography/tandem mass spectrometryChromatographia, 2000
- Comparison of turbulent-flow chromatography with automated solid-phase extraction in 96-well plates and liquid–liquid extraction used as plasma sample preparation techniques for liquid chromatography–tandem mass spectrometryJournal of Chromatography A, 1999
- High-performance liquid chromatographic methods for the determination of a new carbapenem antibiotic, L-749,345, in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- High-throughput solid-phase extraction for the determination of cimetidine in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- The use of turbulent flow chromatography/mass spectrometry for the rapid, direct analysis of a novel pharmaceutical compound in plasmaRapid Communications in Mass Spectrometry, 1997